Amsterdam, Netherlands

John Haanen

This inventor holds 1 USPTO granted patent. Top assignee: Stichting Het Nederlands Kanker Instituut-Antoni Van Leeuwenhoek Ziekenhuis. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: John Haanen. Retrieved from https://idiyas.com/inventor/john-haanen

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 1.0


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: John Haanen: Innovator in Cancer Research

Introduction

John Haanen is a prominent inventor based in Amsterdam, Netherlands. He has made significant contributions to the field of cancer research, particularly in the development of innovative therapies. His work is focused on enhancing the effectiveness of cancer treatments through advanced methodologies.

Latest Patents

Haanen holds a patent for "T Cell Manufacturing Compositions and Methods." This patent represents a crucial advancement in the manufacturing of T cells, which are vital for immunotherapy in cancer treatment. His innovative approach aims to improve the efficacy of these therapies, potentially leading to better patient outcomes.

Career Highlights

John Haanen is affiliated with the Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital. His role at this esteemed institution allows him to collaborate with leading experts in oncology and contribute to groundbreaking research. His dedication to cancer research has positioned him as a key figure in the field.

Collaborations

Haanen works alongside Marit M Van Buuren, a fellow researcher at the Netherlands Cancer Institute. Their collaboration focuses on advancing cancer treatment methodologies and exploring new avenues for immunotherapy.

Conclusion

John Haanen's contributions to cancer research through his patent and collaborative efforts highlight his commitment to improving cancer therapies. His work continues to inspire advancements in the field, making a significant impact on patient care.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…